Call Me Free
Home ›› Products ›› API ›› Alogliptin Benzoate
Previous Product Next Product
Alogliptin Benzoate

Alogliptin Benzoate

Allopurinol API, a potent xanthine oxidase inhibitor, is pivotal in managing chronic gout by effectively reducing urate levels. With a history dating back to its initial FDA approval in 1966, it remains a cornerstone in gout treatment, formulated by various manufacturers to ensure widespread availability. By inhibiting the enzymatic activity of xanthine oxidase, Allopurinol API prevents the formation of uric acid, thereby mitigating the deposition of monosodium urate crystals around joints and tissues. Trusted by healthcare professionals globally, Allopurinol API offers reliable relief and management for individuals battling gout. Always consult healthcare providers for personalized treatment plans tailored to individual medical conditions.
Inquiry Now

Manufacturing Unit-I

Block/Survey No. 497, Mauhuvej, nr. Fairdeal Textile Park, Kosamba, Gujarat 394125, India